FDA
approval
· 2020-02-24
FDA Approved: RANOLAZINE — Supplemental Application (Ajanta Pharma USA Inc.)
Summary
FDA approved a supplemental application for Ranolazine from Ajanta Pharma USA Inc., enabling updated labeling for the generic product.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for RANOLAZINE (RANOLAZINE)